24/7 Market News Snapshot 04 September, 2025 – NanoVibronix, Inc. Common Stock (NASDAQ:NAOV)

September 4, 2025

DENVER, Colo., 04 September, 2025 (www.247marketnews.com) – (NASDAQ:NAOV) are discussed in this article.
NanoVibronix, Inc. (NASDAQ:NAOV) is experiencing a positive surge in its stock performance, currently trading at $6.167 during the pre-market session, reflecting a considerable increase of 12.54% from the previous close of $5.480. This momentum is bolstered by a trading volume of 1.24 million shares, indicative of significant investor enthusiasm and the potential for sustained growth. Key technical indicators suggest that the stock might maintain this upward trajectory, with critical resistance levels identified around $6.50. A breakthrough above this threshold could lead to further gains, whereas support is established at $5.80, making it essential for investors to monitor volume and price movements closely for actionable insights.

In a notable development, NanoVibronix has announced the issuance of U.S. Patent No. 12,402,953 B2 by the United States Patent and Trademark Office. This patent, granted on September 2, 2025, marks a pivotal advancement for the company and its fully owned subsidiary, ENvue Medical Holdings LLC, in the healthcare technology sector. The patented technology presents a cutting-edge method that harmonizes electromagnetic (EM) navigation data with real-time medical imaging techniques, including X-ray, CT, ultrasound, and MRI. This integration allows for enhanced visualization of feeding tubes or catheters on medical images, significantly improving procedural accuracy and minimizing misplacement risks.

Doron Besser, M.D., CEO of NanoVibronix, underscores the distinctive capability of ENvue to merge navigation with imaging, setting the company apart in the industry. The patent not only bolsters NanoVibronix’s leadership in the feeding tube placement market but also opens avenues for future applications in vascular navigation. This aligns with the company’s mission to develop innovative, non-invasive medical solutions that prioritize patient safety and optimize clinical outcomes, reinforcing its commitment to transforming healthcare practices and establishing a robust presence in the medical device arena.

Related news for (NAOV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.